The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells.
about
Human NKG2D-ligands: cell biology strategies to ensure immune recognitionGlycosyl-Phosphatidyl-Inositol (GPI)-Anchors and Metalloproteases: Their Roles in the Regulation of Exosome Composition and NKG2D-Mediated Immune RecognitionPalmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding.Regulation of ligands for the NKG2D activating receptor.The Glycophosphatidylinositol Anchor of the MCMV Evasin, m157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor Recognition.PRL-3 mediates the protein maturation of ULBP2 by regulating the tyrosine phosphorylation of HSP60NKG2D Receptor and Its Ligands in Host DefenseCutting edge: NKG2D-dependent cytotoxicity is controlled by ligand distribution in the target cell membrane.Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.Advances in NKG2D ligand recognition and responses by NK cells.NKG2D signaling in cancer immunosurveillance.Extracellular Mipp1 Activity Confers Migratory Advantage to Epithelial Cells during Collective Migration.NKG2D- and T-cell receptor-dependent lysis of malignant glioma cell lines by human γδ T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitorsA short half-life of ULBP1 at the cell surface due to internalization and proteosomal degradation.Anti-NKG2D mAb: A New Treatment for Crohn's Disease?A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008.NKG2D Ligands-Critical Targets for Cancer Immune Escape and Therapy
P2860
Q21131219-8D8D333D-C8BA-451B-8DDE-1F08C2C2E30CQ28076151-E033D4E0-B8CA-4F56-9601-95C67098771AQ34217314-661BED7D-671E-4DD8-93FE-2CBA6773FB5BQ34321457-0E535633-FBD8-4AE3-894A-4A444BF3F42AQ34806981-7EE3CE00-591D-4A97-A539-AF196F77DC9EQ35163691-373A4F8C-BB8C-4EE1-987B-5366AD7099BBQ35687826-AFD2C32B-175E-48BC-8D96-C97F24B838A3Q37398391-A4A15A5E-D738-4192-BF9F-53672FD8FF44Q38107250-6BEAB833-2BCD-42A4-854F-3FCA40CE41A8Q38180339-712A44CE-0E67-40ED-8924-CCA1B5F71E03Q38194944-2ABBC70A-AF87-45E4-AE71-3D8F8D7B5C32Q38752469-B506DCB4-114C-4B0D-8288-4FB31010FB5CQ39798606-7D254AE6-4C76-4E1B-83E3-C299443E3794Q40144217-5260C47D-F6B5-4172-AD19-EA81DA166FADQ41660377-BF1155C6-B119-4FC5-822E-787F3488B963Q50902514-0687C72A-CA42-4B53-80EE-C7A1B310AE56Q58750637-6893CF77-F243-47E0-A38C-A493017D12B8
P2860
The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The human NKG2D ligand ULBP2 c ...... h forms can activate NK cells.
@en
The human NKG2D ligand ULBP2 c ...... h forms can activate NK cells.
@nl
type
label
The human NKG2D ligand ULBP2 c ...... h forms can activate NK cells.
@en
The human NKG2D ligand ULBP2 c ...... h forms can activate NK cells.
@nl
prefLabel
The human NKG2D ligand ULBP2 c ...... h forms can activate NK cells.
@en
The human NKG2D ligand ULBP2 c ...... h forms can activate NK cells.
@nl
P2093
P2860
P356
P1476
The human NKG2D ligand ULBP2 c ...... th forms can activate NK cells
@en
P2093
Hugh T Reyburn
Lola Fernández-Messina
Omodele Ashiru
Sonia Agüera-González
P2860
P304
P356
10.1242/JCS.076042
P407
P577
2011-01-11T00:00:00Z